SR 3029

SR 3029

CAT N°: 27048
Price:

From 129.00 109.65

SR 3029 is an inhibitor of casein kinase 1? (CK1?) and CK1? (IC50s = 44 and 260 nM, respectively).{47522} It is selective for CK1? and CK1? over 438 kinases in a panel but also inhibits MYLK4, FLT3, Cdk4/cyclin D1, and MARK2 by greater than 90% at 10 µM. SR 3029 inhibits Cdk4/cyclin D1, Cdk4/cyclin D3, Cdk6/cyclin D1, Cdk6/cyclin D3, and FLT3 with IC50 values of 576, 368, 428, 427, and 3,000 nM, respectively. It inhibits proliferation of A375 human melanoma cells in vitro (EC50 = 86 nM). SR 3029 (20 mg/kg per day) reduces tumor growth and increases lifespan in MDA-MB-231 and MDA-MB-468 mouse xenograft models.{47523} It reduces the expression of the Wnt/?-catenin target CCND1 and decreases protein levels of nuclear ?-catenin and cyclin D1 in mouse tumor tissue.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • N-[(6,7-difluoro-1H-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)-2-(4-morpholinyl)-9H-purin-6-amine
  • Correlated keywords
    • SR3029 CK 1? 1? MYL K4 MYLK 4 FLT 3 Cdk MARK 2 6 A 375 MDAMB231 MB231 MDAMB MDAMB468 MB468 CCND
  • Product Overview:
    SR 3029 is an inhibitor of casein kinase 1? (CK1?) and CK1? (IC50s = 44 and 260 nM, respectively).{47522} It is selective for CK1? and CK1? over 438 kinases in a panel but also inhibits MYLK4, FLT3, Cdk4/cyclin D1, and MARK2 by greater than 90% at 10 µM. SR 3029 inhibits Cdk4/cyclin D1, Cdk4/cyclin D3, Cdk6/cyclin D1, Cdk6/cyclin D3, and FLT3 with IC50 values of 576, 368, 428, 427, and 3,000 nM, respectively. It inhibits proliferation of A375 human melanoma cells in vitro (EC50 = 86 nM). SR 3029 (20 mg/kg per day) reduces tumor growth and increases lifespan in MDA-MB-231 and MDA-MB-468 mouse xenograft models.{47523} It reduces the expression of the Wnt/?-catenin target CCND1 and decreases protein levels of nuclear ?-catenin and cyclin D1 in mouse tumor tissue.

We also advise you